Apolipoprotein L 2 anticorps (C-Term)
-
- Antigène Voir toutes Apolipoprotein L 2 (APOL2) Anticorps
- Apolipoprotein L 2 (APOL2) (Apolipoprotein L, 2 (APOL2))
-
Épitope
- C-Term
-
Reactivité
- Humain, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Apolipoprotein L 2 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)
- Specificité
- APOL2 Antibody detects endogenous levels of total APOL2.
- Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogène
- A synthesized peptide derived from human APOL2, corresponding to a region within C-terminal amino acids.
- Isotype
- IgG
- Top Product
- Discover our top product APOL2 Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:1000, IHC: 1:50-1:200, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C. Stable for 12 months from date of receipt.
- Date de péremption
- 12 months
-
- Antigène
- Apolipoprotein L 2 (APOL2) (Apolipoprotein L, 2 (APOL2))
- Autre désignation
- APOL2 (APOL2 Produits)
- Synonymes
- anticorps APOL3, anticorps APOL-II, anticorps Apol8, anticorps APOL2, anticorps apolipoprotein L2, anticorps apolipoprotein L, 2, anticorps APOL2, anticorps Apol2, anticorps LOC619179
- Sujet
-
Description: May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles.
Gene: APOL2
- Poids moléculaire
- 37 kDa
- ID gène
- 23780
- UniProt
- Q9BQE5
- Pathways
- Phosphorylation & l'infection par le SRAS-CoV-2
-